Medtronic’s Talent approved for AAA
This article was originally published in The Gray Sheet
Executive Summary
Medtronic gains PMA approval April 15 for its Talent endovascular stent graft with CoilTrac delivery system for the minimally invasive treatment of abdominal aortic aneurysms. The device is indicated for aneurysms with aortic neck diameters of up to 32 mm and proximal aortic neck lengths as small as 10 mm. Medtronic believes that the device will expand by about 20% the AAA population treatable via an endovascular approach, since currently available systems are indicated for smaller aortic neck diameters and longer aortic neck lengths. Talent will complement Medtronic's AneuRx AAAdvantage abdominal stent graft, which is for diameters of up to 26 mm and lengths of 15 mm or more. Medtronic submitted the Talent PMA last November (1"The Gray Sheet" Dec. 10, 2007, p. 6)
You may also be interested in...
Medtronic’s Endurant stent graft
Endovascular stent graft for repair of abdominal aortic aneurysms will debut in Europe by mid-July following CE mark approval, announced July 7. In the United States, Medtronic anticipates a market launch in three to five years after beginning a clinical trial June 23 to support a planned PMA submission. The study will enroll 150 patients at 30 sites over the next 18 months. The device, which is designed to address aortas that are highly angulated and aneurysms with short necks, will be compared in the study with Medtronic's Talent abdominal stent graft, which was approved by FDA in mid-April ("1The Gray Sheet" April 21, 2008, In Brief). The trial has a primary safety endpoint of no major adverse events within one month of implant and a composite endpoint of successful treatment of aneurysms at one year
Medtronic Files PMA For Talent Abdominal Stent Graft System
A modular PMA for Medtronic's Talent stent graft for minimally invasive treatment of abdominal aortic aneurysms is now complete and has been deemed "fileable" by FDA, according to the company
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.